Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

228 public trials 23 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)

NCT01026415

Conditions
Carcinoma, Carcinomas, Disease, Hodgkin, +14 more
Locations
  • City of Hope Duarte, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • St. Francis Medical Group Oncology & Hematology Specialists Indianapolis, Indiana, United States
  • Karmanos Cancer Institute / Wayne State University Detroit, Michigan, United States
View Trial Details
Completed

Trial to Define the Safety and Tolerability of SGN-40, Rituximab, and Gemcitabine in Patients With DLBCL

NCT00655837

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • University of Colorado Aurora, Colorado, United States
  • Oncology Specialists Park Ridge, Illinois, United States
View Trial Details
Completed

A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma

NCT01015911

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +20 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • UCLA Medical Center / University of California at Los Angeles Los Angeles, California, United States
  • Karmanos Cancer Institute / Wayne State University Detroit, Michigan, United States
View Trial Details
Completed

Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies

NCT00430846

Conditions
Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Washington University St Louis, Missouri, United States
  • Weill Cornell Medical College New York, United States
  • University of Texas/MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

Cardiac Safety Study of Brentuximab Vedotin (SGN-35)

NCT01026233

Conditions
Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • University of Miami Hospital and Clinics, Miller School of Medicine Miami, Florida, United States
View Trial Details
Completed

Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma

NCT00724984

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +24 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Northwestern University Medical School Chicago, Illinois, United States
  • Horizon Oncology Center Lafayette, Indiana, United States
  • University of Massachusetts Medical School Worcester, Massachusetts, United States
View Trial Details
Completed

Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients

NCT00322491

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • UCLA School of Medicine Loa Angeles, California, United States
  • Loyola University Medical Center Maywood, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients

NCT00322387

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Indiana Blood and Marrow Transplantation Beech Grove, Indiana, United States
  • University of Rochester Medical Center Rochester, New York, United States
  • Oregon Health and Science University Portland, Oregon, United States
View Trial Details

Related conditions